Naltrexone effects on cortisol secretion in women and men in relation to a family history of alcoholism: Studies from the Oklahoma Family Health Patterns Project
Section snippets
Overview
The Oklahoma Family Health Patterns Project is a study of healthy young FH+ and FH− adults with the goal of understanding preexisting differences between these groups that might provide insights into risk factors in persons who have not yet developed problem drinking or drug use habits. The parent project currently has 407 participants of whom a subset underwent the naltrexone protocol.
Subjects
Naltrexone testing included 132 subjects (74 females) recruited through community advertisement, however 4
Results
There were no differences between men and women in the FH groups on major demographic and background characteristics (Table 1). Cortisol values on naltrexone and placebo days are shown in Fig. 1. In order to establish that the groups had equivalent levels of cortisol secretion under basal conditions, we carried out a preliminary analysis of cortisol values at each time point on placebo days on sex and FH groups using a repeated measure ANOVA. There was a significant effect of period reflecting
Discussion
The present study confirms that women have larger and longer lasting cortisol responses to 50 mg of naltrexone than do men. Perhaps more interestingly, the results provide no confirmation that FH+ are more reactive than FH− to that dose of naltrexone. These findings provide several points for consideration in relation to naltrexone's utility as a probe for central opioid activity in relation to risk for alcoholism.
In light of our present findings we reexamined studies of cortisol responses to
Role of the funding source
The funding sources had no role in the design of the study or in the analysis and interpretation of the results. The content is solely the view of the authors and does not necessarily represent the official view of the National Institutes of Health or the VA.
Conflict of interest statement
The authors have no financial interest in any product associated with this research.
Acknowledgements
This work was supported by the Department of Veterans Affairs, the National Institutes of Health, NIAAA (R01 AA12207), NIRR (M01 RR14467, UL1 RR025767, KL2 RR025766, and RR025766), and NHLBI (F32 HL083689).
References (53)
- et al.
Influence of naltrexone administration on dehydroepiandrosterone sulfate levels in male and female participants
Biol. Psychol.
(2007) - et al.
Hormonal effects of high dose naloxone in humans
Neuropeptides
(1985) - et al.
Exploring the impact of gender and reproductive status on outcomes in a randomized clinical trial of naltrexone augmentation of nicotine patch
Drug Alcohol Depend.
(2010) - et al.
Naltrexone attenuates acute cigarette smoking behavior
Pharmacol. Biochem. Behav.
(2004) - et al.
Negative affect, pain and sex: the role of endogenous opioids
Pain
(2007) - et al.
Opiate receptors: enkephalins and endorphins
Clin. Endocrinol. Metab.
(1983) - et al.
Adrenocorticotropin and cortisol responses to a naloxone challenge and risk of alcoholism
Biol. Psychiatry
(2002) Influence of the menstrual cycle on neuroendocrine and behavioral responses to an opiate agonist in humans: preliminary results
Psychoneuroendocrinology
(1988)- et al.
Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?
Biol. Psychiatry
(2006) - et al.
Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism
Neuropsychopharmacology
(2002)
Cortisol secretion patterns in addiction and addiction risk
Int. J. Psychophysiol.
Pituitary–adrenal and sympathetic-adrenal correlates of distress and effort
J. Psychosom. Res.
The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics
Eur. Neuropsychopharmacol.
Effects of naltrexone on cortisol levels in heavy drinkers
Pharmacol. Biochem. Behav.
Acute HPA axis response to naltrexone differs in female vs. male smokers
Psychoneuroendocrinology
Blunted hypothalamic-pituitary-adrenocortical axis responsivity to stress in persons with a family history of alcoholism
Int. J. Psychophysiol.
Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity
Psychoneuroendocrinology
Suppression of the HPA axis stress-response: implications for relapse
Alcohol. Clin. Exp. Res.
Attenuated adrenocorticotropic responses to psychological stress are associated with early smoking relapse
Psychopharmacology (Berl.)
Sex differences in pain and hypothalamic-pituitary-adrenocortical responses to opioid blockade
Psychosom. Med.
Effects of the opiate agonist loperamide on pituitary–adrenal function in patients with suspected hypercortisolism
J. Endocrinol. Invest.
Diagnostic and Statistical Manual of Mental Disorders
The family history method using diagnostic criteria. Reliability and validity
Arch. Gen. Psychiatry
Continuous infusion of naloxone in the treatment of narcotic overdose
Drug Intell. Clin. Pharm.
High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses
Arch. Gen. Psychiatry
Attenuated cortisol response to biobehavioral stressors in sober alcoholics
J. Stud. Alcohol
Cited by (29)
Pre-training naltrexone increases conditioned fear learning independent of adolescent alcohol consumption history
2021, Physiology and BehaviorCitation Excerpt :For example, administration of the opioid receptor antagonist naltrexone (an opioid receptor antagonist that is preferentially effective on mu opioid receptors [MORs]) decreases alcohol consumption and self-administration in a dose-dependent manner [19, 34-37] and facilitates fear acquisition [33]. Previous research has also shown that human individuals with a family history of alcoholism exhibit greater release of cortisol after administration of the opioid receptor antagonists naltrexone or naloxone than individuals without a family history of alcoholism [46, 47] (but see [48]). Conversely, antagonists of another type of opioid receptor, the kappa opioid receptors (KORs), decrease fear learning and/or expression [31, 38] and either decrease or have no effect on alcohol consumption or alcohol self-administration [39-45].
The influence of stress and early life adversity on addiction: Psychobiological mechanisms of risk and resilience
2020, International Review of NeurobiologySex differences in the effect of bupropion and naltrexone combination on alcohol drinking in mice
2019, Pharmacology Biochemistry and BehaviorCitation Excerpt :Therefore, combination medications modulating multiple neuronal systems may have enhanced efficacy over monotherapy strategies. Drug abuse is affected by gender (Chartoff and McHugh, 2016), and there is a need to consider gender differences in alcohol research because men and women respond differently to potential treatments (Lovallo et al., 2012; Clayton and Collins, 2014; O'Malley et al., 2018). For an example, naltrexone treatment has been found to reduce alcohol consumption with or without gender differences (Pettinati et al., 2008; Krishnan-Sarin et al., 2007; Garbutt et al., 2005; Hernandez-Avila et al., 2006; Greenfield et al., 2010).
Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans
2018, Hormones and BehaviorPharmacogenomics in Psychiatric Practice
2016, Clinics in Laboratory MedicineSocial Isolation and Ethanol Drinking: A Preclinical Model of Addiction Vulnerability in Males, but Not Females
2016, Neuropathology of Drug Addictions and Substance Misuse